CLINICAL_TRIALS
trial_result
· 2025-10-07
Clinical Trial Update: Exploratory Study of the Expression of the Serotonergic 5-HT4 Receptor in Parkinson's Disease [NA]
Summary
An exploratory study assessing expression of the serotonin 5-HT4 receptor in Parkinson's disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hospices Civils de Lyon | Conditions: Parkinson Disease | NA | Status: COMPLETED